USPTO

AIM ImmunoTech Expands Ampligen Patent Protection in Europe and U.K. Through 2041

OCALA, Fla., Sept. 2, 2026 AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharmaceutical company developing Ampligen® (rintatolimod), announced that...

By cGxPwire Editor
September 3, 2026

.Clinical

HCW Biologics Strengthens HCW9302 Patent for Alopecia Areata

MIRAMAR, Fla., Sept. 2, 2026 HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing fusion immunotherapeutics for autoimmune...

By cGxPwire Editor
September 3, 2026

Bio-Pharma

PharmAla Advances MDXX Manufacturing and Drug Pipeline

Toronto, Ontario, Canada, August 21, 2026 PharmAla Biotech Holdings Inc., a biotechnology company focused on the research, development, and...

By cGxPwire Editor
August 24, 2026

MedTech

RenovoRx Expands RenovoCath Patent Protection for Cancer

Mountain View, California, U.S. | August 20, 2026 RenovoRx announced that the U.S. Patent and Trademark Office (USPTO) has...

By cGxPwire Editor
August 21, 2026

Bio-Pharma

Artelo Biosciences Secures U.S. Patent Allowance for ART27.13

Solana Beach, California — August 17, 2026 Artelo Biosciences, Inc. announced that the U.S. Patent and Trademark Office (USPTO)...

By cGxPwire Editor
August 18, 2026

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

Bio-Pharma

Acurx Advances Ibezapolstat Toward Phase 3 Development

Staten Island, New York, August 17, 2026 Acurx Pharmaceuticals, Inc., a late-stage biopharmaceutical company developing antibiotics for difficult-to-treat bacterial...